Neo Ivy Capital Management’s Southern Copper SCCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.6K Buy
+276
New +$49.6K 0.01% 311
2025
Q4
Sell
-2,102
Closed -$245K 512
2025
Q3
$245K Buy
+2,102
New +$204K 0.06% 284
2025
Q2
Sell
-23,814
Closed -$2.1M 459
2025
Q1
$2.1M Buy
+23,814
New +$2.11M 0.67% 53
2022
Q4
$122K Buy
+2,214
New +$112K 0.08% 252
2022
Q2
Sell
-795
Closed -$56K 588
2022
Q1
$56K Buy
+795
New +$50.3K 0.05% 361
2021
Q3
Sell
-2,576
Closed -$152K 613
2021
Q2
$152K Buy
2,576
+1,644
+176% +$106K 0.15% 214
2021
Q1
$58K Buy
+932
New +$61.3K 0.06% 314
2020
Q4
Sell
-5,685
Closed -$235K 556
2020
Q3
$235K Buy
+5,685
New +$233K 0.24% 167
2020
Q2
Sell
-1,784
Closed -$46K 581
2020
Q1
$46K Buy
+1,784
New +$59.1K 0.07% 324

Other funds holding SCCO

Neo Ivy Capital Management's SCCO Position: Q2 2026 in Review

Neo Ivy Capital Management opened a new position in Southern Copper (SCCO) in Q2 2026: 276 shares worth $47.6K. The stake represents 0.01% of the portfolio and ranks #311 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in SCCO as recently as Q3 2025.

Neo Ivy Capital Management first reported a position in SCCO in Q1 2020 and has held it in 9 quarters since. The position peaked at $2.1M in Q1 2025. 858 funds tracked by Wall St. Rank hold SCCO as of Q2 2026.

  • Neo Ivy Capital Management held 276 shares of Southern Copper worth $47.6K as of Q2 2026.
  • Southern Copper was a new Neo Ivy Capital Management position in Q2 2026.
  • Southern Copper made up 0.01% of Neo Ivy Capital Management's portfolio in Q2 2026, its #311 holding.
  • Neo Ivy Capital Management first reported a position in Southern Copper in Q1 2020 and has held it in 9 quarters since.
  • Neo Ivy Capital Management's Southern Copper position peaked at $2.1M in Q1 2025.
  • 858 funds tracked by Wall St. Rank held Southern Copper as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.